Healthcare -
Biotechnology - NASDAQ - US
$ 48.435
7.68 %
$ 3.15 B
Market Cap
-15.32
P/E
KYMR - NET INCOME
Net Income KYMR - Kymera Therapeutics, Inc.
-224 M
LAST VALUE
-20.25%
2 YEAR CAGR
-40.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR